Delivery Order SPE2DB22D2211-SPE2DB23FNTZ1
Award Date 7/19/23
Potential Completion Date 8/9/23
Potential Value $23K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $226,187.20 firm fixed price delivery order to Amerisourcebergen Drug Corporation for Ocrevus 300 mg/10 ml vials. Amerisourcebergen, a subsidiary of Amerisourcebergen Corporation, will deliver the multiple sclerosis treatment to a facility in Conshohocken, Pennsylvania by October 17, 2023 under the prime contract vehicle. No set aside designation or subcontractors were indicated. This supports the Defense Logistics Agency's mission to provide medical...
- The Defense Logistics Agency awarded a $51,275.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 28, 2026, for the supply of Ocrevus 300 mg/10 mL vials. This competitive award with no set-aside designation is scheduled for completion by February 19, 2026, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract represents a task order under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $116,362.50 on November 10, 2025, for the supply of Ocrevus 300 mg/10 mL vials. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of December 3, 2025, and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX),...
- The Defense Logistics Agency awarded a $48,077.16 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Ocrevus 300 mg/10 mL vials on September 19, 2025, with an ultimate completion date of October 10, 2025. This non-competitive delivery order was placed against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and extending through December 2026. The product will be delivered to AmerisourceBergen's...
- The Defense Logistics Agency awarded a $67,856.16 firm fixed price delivery order to Amerisourcebergen Drug Corporation for OCREVUS 300 MG/10 ML vials. Amerisourcebergen, a subsidiary of Amerisourcebergen Corporation, will deliver the multiple sclerosis treatment to a facility in Conshohocken, Pennsylvania by August 30th, 2023 under the prime contract vehicle. No set aside designation or subcontractors were indicated. This supports the Defense Logistics Agency's mission to provide medical...
- The Defense Logistics Agency awarded a $120,192.80 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Ocrevus (ocrelizumab) 300 mg/10 mL vials. This is a non-set-aside competitive award with an ultimate completion date of October 9, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the contract at its corporate office location. The delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a $45,237 delivery order to Amerisourcebergen Drug Corporation for Ocrevus 300 MG/10 ML vials. Under this firm fixed price contract, Amerisourcebergen will provide 10 mL vials of the multiple sclerosis treatment Ocrevus to support the Defense Logistics Agency's medical supply needs. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a three week period concluding in mid-August. No subcontractors or set aside designations...
- The Defense Logistics Agency awarded a delivery order valued at $24,038.58 to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Ocrevus 300 mg/10 mL vials. This is a firm fixed price delivery order with an ultimate completion date of June 24, 2025, and represents a non-competitive, non-set-aside award. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a $76,913.10 delivery order to AmerisourceBergen Drug Corp on January 30, 2026, for the supply of Ocrevus 300 mg/10 mL vials. This is a firm fixed-price contract with a completion date of February 23, 2026, and represents a non-competitive set-aside award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare...
- The Defense Logistics Agency has awarded a delivery order valued at $360,578.40 to AmerisourceBergen Drug Corp for the supply of Ocrevus (ocrelizumab) 300 mg/10 ml vials. This is a firm fixed-price delivery order with an ultimate completion date of October 21, 2025, issued under a competitive procurement with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement,...